Skip to main content
. Author manuscript; available in PMC: 2024 Jul 5.
Published in final edited form as: Urology. 2023 Apr 5;177:81–88. doi: 10.1016/j.urology.2023.02.045

Table 1.

Patients’ baseline characteristics by treatments received.

N Total 2597 Radical cystectomy 1321 Trimodal therapy 323 Non-standard treatments 953
Age, years
 < 60 507 (19.5) 335 (25.4) 27 (8.4) 145 (15.2)
 60–69 697 (26.8) 423 (32.0) 61 (18.9) 213 (22.4)
 70–79 725 (27.9) 412 (31.2) 101 (31.3) 212 (22.2)
 > 80 668 (25.7) 151 (11.4) 134 (41.5) 383 (40.2)
Race/ethnicity
 Non-Hispanic White 2391 (92.1) 1228 (93.0) 291 (90.1) 872 (91.5)
 Non-White 206 (7.9) 93 (7.0) 32 (9.9) 81 (8.5)
Sex
 Male 1923 (74.0) 1016 (76.9) 223 (69.0) 684 (71.8)
 Female 674 (26.0) 305 (23.1) 100 (31.0) 269 (28.2)
Tumor stage
 < =T2 1658 (63.8) 582 (44.1) 271 (83.9) 805 (84.5)
 T3 628 (24.2) 544 (41.2) 30 (9.3) 54 (5.7)
 T4 311 (12.0) 195 (14.8) 22 (6.8) 94 (9.9)
Nodal stage
 N0/Nx 2140 (82.4) 982 (74.3) 294 (91.0) 864 (90.7)
 > =N1 457 (17.6) 339 (25.7) 29 (9.0) 89 (9.3)
Health insurance type
 Private 758 (29.2) 483 (36.6) 46 (14.2) 229 (24.0)
Medicare 1500 (57.8) 654 (49.5) 246 (76.2) 600 (63.0)
 Medicaid 156 (6.0) 99 (7.5) 13 (4.0) 44 (4.6)
 Other/Uninsured/Unknown 183 (7.0) 85 (6.4) 18 (5.6) 80 (8.4)
Rurality of residence
 Urban 2205 (84.9) 1117 (84.6) 279 (86.4) 809 (84.9)
 Large Town 252 (9.7) 135 (10.2) 24 (7.4) 93 (9.8)
 Rural 140 (5.4) 69 (5.2) 20 (6.2) 51 (5.4)
Area Deprivation Index
 Q1 650 (25.0) 337 (25.5) 79 (24.5) 234 (24.6)
 Q2 642 (24.7) 326 (24.7) 83 (25.7) 233 (24.4)
 Q3 652 (25.1) 335 (25.4) 76 (23.5) 241 (25.3)
 Q4 653 (25.1) 323 (24.5) 85 (26.3) 245 (25.7)

NOTE: frequency with column percents are presented. Trimodal therapy includes transurethral resection of the bladder tumor, chemotherapy, and radiation. Non-standard treatments describe cases in which patients underwent only one or two of the trimodal treatment modalities.

*

All percentages may not add up to 100 due to rounding.